US Food and Drug Administration grants ‘accelerated approval’ to drug that ‘slows down’ Alzheimer’s
Washington, USA (CNN) – The US Food and Drug Administration (FDA) on Friday granted accelerated approval for the Alzheimer’s drug lecanemab, one of the first experimental dementia drugs that appears to slow cognitive decline. “Alzheimer’s disease disrupts the lives of those who suffer from it immeasurably and has devastating effects on their loved ones,” Dr. … Read more